Application and Interpretation of an Interferon-Gamma Release Assay: Results of an Audit in a Canadian Centre
BACKGROUND: Interferon-gamma release assays (IGRAs) are newly approved for diagnosing latent tuberculosis infection (LTBI). An internal audit was conducted to review the use of a newly implemented IGRA at the Hôpital du Sacré-Coeur de Montréal (Montréal, Québec) to evaluate its concordance with Cana...
Saved in:
Main Authors: | Sopharat Vat, Marc Ghannoum, Pierre Laflamme, Mario Dugas, Manon Labrecque, Valéry Lavergne |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2012/838465 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interferon-Gamma Release Assays for Screening of Health Care Workers in Low Tuberculosis Incidence Settings: Dynamic Patterns and Interpretational Challenges
by: Madhukar Pai, et al.
Published: (2012-01-01) -
Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis
by: Xidong He, et al.
Published: (2020-01-01) -
Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes
by: S.J.W. Kang, et al.
Published: (2024-10-01) -
Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.
by: Jason D Simmons, et al.
Published: (2023-01-01) -
Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays
by: Sandra Schwarzlose-Schwarck, et al.
Published: (2025-02-01)